OGIVRI
NDC 67457-847, trastuzumab, kit, from Mylan Institutional LLC.
- Product NDC
- 67457-847
- Status
- Listed
- Labeler
- Mylan Institutional LLC
- Dosage form
- KIT
- Route
- —
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761074
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67457-847 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67457-847-44 | 67457084744 | 1 KIT in 1 CARTON (67457-847-44) * 20 mL in 1 VIAL, MULTI-DOSE (67457-845-50) * 20 mL in 1 VIAL (67457-846-20) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6b7938e6-14c7-4a65-9605-967542ecfb8fMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=67457-847
Use it
Look up 67457-847 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67457-847 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67457-847. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.